Stockscreener 앱 받기
10.05
9.78%
-1.09
시간 외 거래:
10.08
0.03
+0.30%
전일 마감가:
$11.14
열려 있는:
$11.06
하루 거래량:
291.91K
Relative Volume:
0.77
시가총액:
$453.43M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-3.92%
1개월 성능:
-33.44%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$10.04
$11.06
1주일 범위
$10.03
$11.23
52주 변동 폭
$8.89
$24.36
Beta Bionics Inc Stock (BBNX) Company Profile
명칭
Beta Bionics Inc
전화
949-427-7785
주소
11 HUGHES, IRVINE
BBNX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BBNX
Beta Bionics Inc
|
10.05 | 453.43M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
129.89 | 221.92B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
93.58 | 139.43B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
339.59 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
81.80 | 104.24B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
69.20 | 40.93B | 5.72B | 4.17B | 259.90M | 6.97 |
Beta Bionics Inc Stock (BBNX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-24 | 개시 | BofA Securities | Buy |
| 2025-02-24 | 개시 | Lake Street | Buy |
| 2025-02-24 | 개시 | Leerink Partners | Outperform |
| 2025-02-24 | 개시 | Piper Sandler | Overweight |
| 2025-02-24 | 개시 | Stifel | Buy |
| 2025-02-20 | 개시 | Ladenburg Thalmann | Neutral |
| 2025-02-20 | 개시 | Robert W. Baird | Neutral |
모두보기
Beta Bionics Inc 주식(BBNX)의 최신 뉴스
Midday Stock Roundup: Markets Drop around 3% Across the Board - Orange County Business Journal
Beta Bionics to Announce First Quarter 2025 Financial Results on May 6, 2025 - GlobeNewswire
Beta Bionics, Inc. to Release First Quarter 2025 Financial Results on May 6, 2025 - Nasdaq
Midday Stock Roundup: Evolus, ICU Medical down - Orange County Business Journal
Beta Bionics to Host Investor Event on June 22, 2025 - The Manila Times
CUBE LAUNCHES REGPLATFORM™ INTEL TO TRANSFORM THE MID-MARKET REGULATORY INTELLIGENCE LANDSCAPE IN FINANCIAL SERVICES - The Globe and Mail
Stifel maintains Buy rating on Beta Bionics stock, target at $25 - Investing.com Canada
SCHD ETF News, 4/2/2025 - The Globe and Mail
Beta Bionics, Inc.: Undervalued Growth Opportunity with Strategic Expansion Plans - TipRanks
Beta Bionics shares ‘too cheap’ with estimates going higher, says BofA - TipRanks
Beta Bionics Explodes to $65.1M in Revenue - Orange County Business Journal
Midday Stock Roundup: Rivian Rises - Orange County Business Journal
Newly public Beta Bionics reports sales surge; Dexcom hires CCO - MedTech Dive
Beta Bionics welcomes new board member Gerard Michel By Investing.com - Investing.com Australia
Beta Bionics appoints new board member from Delcath Systems By Investing.com - Investing.com South Africa
Beta Bionics appoints new board member from Delcath Systems - Investing.com India
Beta Bionics welcomes new board member Gerard Michel - Investing.com
Beta Bionics Appoints Gerard Michel as Director - TipRanks
Beta Bionics Announces Board Appointment of Gerard Michel - The Manila Times
Stifel maintains Buy on Beta Bionics stock, $25 price target By Investing.com - Investing.com South Africa
Piper Sandler maintains $26 target on Beta Bionics stock By Investing.com - Investing.com Australia
Piper Sandler maintains $26 target on Beta Bionics stock - Investing.com
Stifel maintains Buy on Beta Bionics stock, $25 price target - Investing.com India
Beta Bionics Reports Strong Growth and Strategic Advances - TipRanks
Beta Bionics Inc (BBNX) Reports Q4 2024 Revenue of $20.4M and Ne - GuruFocus.com
Earnings call transcript: Beta Bionics Q4 2024 sees strong revenue growth - Investing.com Australia
Earnings call transcript: Beta Bionics Q4 2024 sees strong revenue growth By Investing.com - Investing.com South Africa
Beta Bionics stock surges as Q4 revenue more than doubles By Investing.com - Investing.com South Africa
Beta Bionics stock surges as Q4 revenue more than doubles - Investing.com Australia
Beta Bionics Announces Fourth Quarter and Full Year 2024 Financial Results and Introduces Annual Guidance for Full Year 2025 - The Manila Times
Beta Bionics Announces Fourth Quarter and Full Year 2024 - GlobeNewswire
Mining Stock Catches Early Bid Following Bullish Analyst Shift - The Globe and Mail
Head to Head Survey: Arch Therapeutics (OTCMKTS:ARTH) & Beta Bionics (NASDAQ:BBNX) - Defense World
Beta Bionics, Inc.’s Quiet Period Will Expire on March 11th (NASDAQ:BBNX) - Defense World
Beta Bionics, Inc. (BBNX): Among Stocks With At Least $10 Million In Insider Spending Recently - Insider Monkey
Beta Bionics Inc (BBNX) 재무 분석
Beta Bionics Inc (BBNX)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.79%
자본화:
|
볼륨(24시간):